Home
Joel Lewis, President and CEO: Galectin Therapeutics GALT Sell · Filed 25/11/19
Trade details
- Type
- Insider sale
- Amount
- $94,707.2
- Shares · price
- 15,680 sh · $6.04 a share
- Held after
- 832,592 sh
- Trade date
- 25/11/17
- Filed
- 25/11/19
- Days to filing
- 2 days
Sold 1.8% of holdings
- Share of holding sold
- 1.8%
Galectin Therapeutics trades, last 26 weeks
What else happened in Galectin Therapeutics around then
Filed or reported within 30 days of the trade day · 25/10/18~25/12/17Joel Lewis's recent trades
- Joel Lewis
Sell10b5-1 planGalectin Therapeutics
Sell10b5-1 planGalectin Therapeutics
GALT
$135K
37,698 sh
$135K
Filed 01/06
Traded 01/06
- Joel Lewis
Sell10b5-1 planGalectin Therapeutics
Sell10b5-1 planGalectin Therapeutics
GALT
$108.4K
27,731 sh
$108.4K
Filed 01/06
Traded 01/05
- Joel Lewis
Sell10b5-1 planGalectin Therapeutics
Sell10b5-1 planGalectin Therapeutics
GALT
$78K
18,571 sh
$78K
Filed 01/06
Traded 01/02
- Joel Lewis
Planned sale10b5-1 planGalectin Therapeutics
Planned sale10b5-1 planGalectin Therapeutics
GALT
$352.8K
84,000 sh
$352.8K
Filed 01/02
Traded 01/02
- Joel Lewis
Sell10b5-1 planGalectin Therapeutics
Sell10b5-1 planGalectin Therapeutics
GALT
$55.3K
7,829 sh
$55.3K
Filed 25/12/19
Traded 25/12/17